← Back to Search

Choice Architecture Nudge for Opioid Use Disorder (PRINCE Trial)

N/A

Waitlist Available

Led By Ezra Golberstein, PhD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

PRINCE Trial Summary

This trial will test whether EHR-based decision support tools can help PCPs make more informed decisions about pain treatment and opioid prescribing, based on principles of behavioral economics.

Eligible Conditions

Opioid Use Disorder
Opioid Addiction

PRINCE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Opioid Tapering Rate

Secondary outcome measures

Prescription Reduction vs Discontinuation Rate

Other outcome measures

Prescription Increase Rate

PRINCE Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: PMP Integration & NudgeExperimental Treatment1 Intervention

Clinics in this arm will receive the Prescription Drug Monitoring (PMP) Integration & Nudge intervention.

Group II: Choice Architecture Nudge + PMP Integration & NudgeExperimental Treatment2 Interventions

Clinics in this arm will receive both the choice architecture nudge and prescription drug monitoring (PMP) integration & nudge interventions.

Group III: Choice Architecture NudgeExperimental Treatment1 Intervention

Clinics in this arm will receive the choice architecture nudge intervention.

Group IV: Care as UsualActive Control1 Intervention

Clinics assigned to this arm will continue to care for the patients as usual in regards to opioid prescribing.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Choice Architecture Nudge

2020

N/A

~1270

PMP Integration & Nudge

2020

N/A

~1270

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,377 Previous Clinical Trials

1,587,666 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,464 Previous Clinical Trials

2,617,962 Total Patients Enrolled

Ezra Golberstein, PhDPrincipal InvestigatorUniversity of Minnesota

2 Previous Clinical Trials

1,262 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been recruited to take part in this experiment?

"Affirmative. According to the clinicaltrials.gov database, this medical trial is currently enrolling participants; it was initially published on August 26th 2020 and recently updated on August 3rd 2022. 631 people must be enrolled from a single site in order for the study to move forward."

Answered by AI

Are individuals still able to partake in this experiment?

"Indeed, data hosted on clinicaltrials.gov attests to this research trial's active recruitment status. The study first appeared on August 26th 2020 and was last updated in early August 2022 - 631 participants are targeted for enrollment at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population

2020. "PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04601480.